Zimmer Biomet HoldingsXSWX:ZBH +0.68%69 Dividend Payout Ratio is 0.12 as of Mar. 2026, which is at its 10-year median of 0.12. GuruFocus rates XSWX:ZBH with a GF Score™ of 69/100 and a GF Value™ of CHF100.92 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 281 Medical Devices & Instruments companies, Zimmer Biomet Holdings ranks better than 94.31% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Zimmer Biomet Holdings's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.12.
The historical rank and industry rank for Zimmer Biomet Holdings's Dividend Payout Ratio or its related term are showing as below:
XSWX:ZBH'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11 Med: 0.12 Max: 0.17
Current: 0.11
During the past 13 years, the highest Dividend Payout Ratio of Zimmer Biomet Holdings was 0.17. The lowest was 0.11. And the median was 0.12.
XSWX:ZBH's Dividend Payout Ratio is ranked better than 94.31% of 281
companies
in the Medical Devices & Instruments industry
Industry Median: 0.42
vs XSWX:ZBH: 0.11
During the past 13 years, the highest Trailing Annual Dividend Yield of Zimmer Biomet Holdings was 1.17%. The lowest was 0.56%. And the median was 0.82%.
During the past 10 years, the average Dividends Per Share Growth Rate was 0.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Zimmer Biomet Holdings was 6.90% per year. The lowest was 0.00% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Zimmer Biomet Holdings (XSWX:ZBH) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Zimmer Biomet Holdings Dividend Payout Ratio Related Terms
Zimmer Biomet Holdings Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Zimmer Biomet Holdings's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings Dividend Payout Ratio Chart
XSWX:ZBH vs PEN, GMED, STE: Dividend Payout Ratio Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings Dividend Payout Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Dividend Payout Ratio falls into.
Zimmer Biomet Holdings Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Zimmer Biomet Holdings's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (XSWX:ZBH) has a Dividend Payout Ratio of 0.12 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Zimmer Biomet Holdings and its competitors. This is near median its historical median of 0.12. Over the past decade, Zimmer Biomet Holdings' Dividend Payout Ratio has ranged from 0.11 to 0.17. According to the industry distribution chart, Zimmer Biomet Holdings ranks #16 out of 281 companies in the Medical Devices & Instruments industry, placing it in the top 5.7%.
Is Zimmer Biomet Holdings' Dividend Payout Ratio too high?
Zimmer Biomet Holdings' current Dividend Payout Ratio of 0.12 is near median its 10-year median of 0.12. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.17. The Medical Devices & Instruments industry median Dividend Payout Ratio is 0.42. Zimmer Biomet Holdings' value of 0.12 is 71.4% below this industry median. Based on the distribution chart, Zimmer Biomet Holdings ranks #16 out of 281 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zimmer Biomet Holdings has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Dividend Payout Ratio compare to PEN and GMED?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #16 out of 281 companies for Dividend Payout Ratio. This places Zimmer Biomet Holdings in the top 6% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.42. Zimmer Biomet Holdings' value of 0.12 is 71.4% below this benchmark. Historically, Zimmer Biomet Holdings' own Dividend Payout Ratio has ranged from 0.11 to 0.17 over the past decade. While the company's 10-year median is 0.12 vs. the industry median of 0.42, Zimmer Biomet Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Devices & Instruments company?
The median Dividend Payout Ratio among Medical Devices & Instruments companies is 0.42, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zimmer Biomet Holdings's current Dividend Payout Ratio of 0.12 is 71.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Zimmer Biomet Holdings and its competitors. For the Medical Devices & Instruments industry, the median Dividend Payout Ratio is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zimmer Biomet Holdings's current Dividend Payout Ratio is 0.12, which is near median its own 10-year median of 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF100.92, compared to a current price of CHF74.50 — trading 26.2% below its estimated fair value. The current Dividend Payout Ratio is 0.12, which is near median its 10-year median of 0.12 and 71.4% below the Medical Devices & Instruments industry median of 0.42. Zimmer Biomet Holdings' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Dividend Payout Ratio is 0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF74.50 is trading 26.2% below its estimated GF Value™ of CHF100.92.
GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.
Key valuation signals for XSWX:ZBH:
Dividend Payout Ratio: 0.12 (near median its 10-year median of 0.12)
GF Value™: CHF100.92 vs. price of CHF74.50 (26.2% below fair value)
Industry Position: 71.4% below the Medical Devices & Instruments median (#16 of 281)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
69GF Score
Get the complete analysis for XSWX:ZBH
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
